QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$39.69 USD
-1.13 (-2.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $39.67 -0.02 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,998 | 3,266 | 1,699 | 1,662 | 535 |
Cost Of Goods | 1,503 | 1,330 | 428 | 313 | 214 |
Gross Profit | 1,494 | 1,936 | 1,271 | 1,349 | 321 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,355 | 1,092 | 365 | 289 | 228 |
Income After Depreciation & Amortization | 139 | 844 | 906 | 1,060 | 93 |
Non-Operating Income | -21 | -32 | 0 | -10 | -1 |
Interest Expense | 148 | 76 | 6 | 10 | 15 |
Pretax Income | -29 | 736 | 900 | 1,040 | 77 |
Income Taxes | -19 | 187 | 196 | 230 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -10 | 549 | 704 | 810 | 73 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -10 | 549 | 704 | 810 | 73 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 596 | 1,117 | 965 | 1,117 | 154 |
Depreciation & Amortization (Cash Flow) | 457 | 273 | 59 | 56 | 62 |
Income After Depreciation & Amortization | 139 | 844 | 906 | 1,060 | 93 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 66.80 | 57.40 | 42.87 | 43.59 | 43.11 |
Diluted EPS Before Non-Recurring Items | 4.13 | 13.76 | 17.27 | 19.55 | 2.73 |
Diluted Net EPS (GAAP) | -0.15 | 9.56 | 16.43 | 18.60 | 1.73 |
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 742.60 | 744.00 | 665.10 | 846.10 |
Cost Of Goods | NA | 361.30 | 375.90 | 368.70 | 397.50 |
Gross Profit | NA | 381.30 | 368.10 | 296.40 | 448.60 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 341.20 | 341.80 | 323.30 | 349.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 40.10 | 26.30 | -26.90 | 99.60 |
Non-Operating Income | NA | -12.60 | -4.10 | -1.00 | -2.90 |
Interest Expense | NA | 36.70 | 37.70 | 36.50 | 36.70 |
Pretax Income | NA | -9.20 | -15.50 | -64.40 | 60.00 |
Income Taxes | NA | -16.20 | -2.80 | -11.20 | 11.20 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 7.00 | -12.70 | -53.20 | 48.80 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 7.00 | -12.70 | -53.20 | 48.80 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 67.30 | 66.90 | 66.80 | 67.10 |
Diluted EPS Before Non-Recurring Items | NA | 1.17 | 0.90 | 0.26 | 1.79 |
Diluted Net EPS (GAAP) | NA | 0.11 | -0.19 | -0.80 | 0.73 |